Vor Biopharma VOR
$ 0.86
-2.67%
Quarterly report 2024-Q3
added 11-07-2024
Vor Biopharma Financial Statements 2011-2024 | VOR
Annual Financial Statements Vor Biopharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
121 M | 199 M | 276 M | - | - | - | - | - | - | - | - | - | - |
Shares |
67.2 M | 39.6 M | 33.4 M | - | - | - | - | - | - | - | - | - | - |
Historical Prices |
1.8 | 5.02 | 8.25 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-118 M | -92.1 M | -68.9 M | -43.3 M | -10.8 M | -4.15 M | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-126 M | -93.4 M | -69 M | -43.4 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-123 M | -90.9 M | -67.6 M | -42.7 M | -10.2 M | -2.84 M | - | - | - | - | - | - | - |
Operating Expenses |
126 M | 93.4 M | 69 M | 43.4 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
31.7 M | 28.9 M | 21.5 M | 11.7 M | 4.22 M | 427 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Vor Biopharma
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
68.5 M | 68.3 M | 67.9 M | 67.6 M | 67 M | 66.3 M | 66 M | 38 M | 37.4 M | 37.3 M | 37.2 M | 36.9 M | 36.8 M | 22.3 M | 505 K | 228 K | 156 K | 145 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-27.6 M | -27.8 M | - | -33.2 M | -30 M | -28.4 M | - | -23.8 M | -21.7 M | -22.7 M | - | -18.6 M | -18.4 M | -13.7 M | - | -11.8 M | -8.04 M | -7.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-28.5 M | -29 M | - | -35.3 M | -32.2 M | -30.4 M | - | -24.1 M | -21.8 M | -22.8 M | - | -18.6 M | -18.4 M | -13.7 M | - | -11.8 M | -8.04 M | -7.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-27.6 M | -28.1 M | - | -34.4 M | -31.3 M | -29.6 M | - | -23.2 M | -21.2 M | -22.4 M | - | -18.3 M | -18 M | -13.4 M | - | -11.6 M | -7.94 M | -7.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
28.5 M | 29 M | - | 35.3 M | 32.2 M | 30.4 M | - | 24.1 M | 21.8 M | 22.8 M | - | 18.6 M | 18.4 M | 13.7 M | - | 11.8 M | 8.04 M | 7.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.7 M | 7.21 M | - | 7.71 M | 8.28 M | 8.51 M | - | 7.23 M | 6.46 M | 7.52 M | - | 5.68 M | 5.41 M | 4.79 M | - | 3.64 M | 2.06 M | 1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency